US Generic Injectables Market Analysis, Top Companies, New Technology, Demand and Opportunity

-

The latest report by IMARC Group, titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, finds that the US generic injectables market reached a value of US$ 10.7 Billion in 2017, growing at a CAGR of more than 9% during 2010-2017. Generic injectables are used as an alternative to innovator injectables without compromising the effectiveness of the treatment. They are available in the market only after the expiry of the innovator injectables. Generic injectables are extensively used for treating numerous life-threatening and chronic diseases such as cardiovascular diseases, respiratory diseases, diabetes, rheumatoid arthritis, cancer, osteoporosis and osteoarthritis. They are less expensive than their branded counterparts, thereby contributing in substantial savings for the patients and healthcare providers.

Request to get the sample report: https://www.imarcgroup.com/us-generic-injectables-market/requestsample

Highlights of the US generic injectables market:
  • Expiry of branded injectables is expected to drive the growth of the market in the coming years.
  • The majority of generic injectables are distributed through hospitals.
  • On the basis of therapeutic area, oncology generic injectables account for the majority of the market share.
The US generic injectables market is being driven by numerous favourable factors. Due to sedentary lifestyles, poor eating habits and ageing population, an increasing number of people are suffering from various chronic diseases. As the treatment of these diseases depends on the use of generic injectables for improved effectiveness and cost savings, this has facilitated the growth of the market. Moreover, several branded injectables worth billions of dollars are projected to lose their patent protection in the coming years. This is expected to provide ample opportunities to the generic manufacturers so as to expand their business. Further, the low cost of generic injectables makes them an affordable healthcare option, owing to which the US government is supporting the production of these drugs. Besides this, the low competition in the market results in increased profit margins for the manufacturers. On account of these factors, the market is projected to reach a value of US$ 17.5 Billion by 2023.

The market has been analysed on the basis of therapeutic area where oncology represents the largest segment, followed by anaesthesia, anti-infectives, parenteral nutrition and cardiovascular diseases. On the basis of containers, vials dominate the market, accounting nearly two-thirds of the total share. Vials are followed by ampoules, premix and prefilled syringes. On the basis of distribution channel, hospitals account for the majority of the total sales, followed by retail pharmacy. After analysing the competitive landscape, it is found that the key players operating in the market include Hospira (Pfizer), Hikma, APP (Fresenius Kabi), Sagent, Sandoz (Novartis) and Henry Shein.

Explore Related Research Reports: https://www.imarcgroup.com/us-generic-injectables-market

The report has examined the US generic injectables market on the basis of:

Therapeutic Area:
  • Oncology
  • Anaesthesia
  • Anti-infectives
  • Parenteral Nutrition
  • Cardiovascular
Containers:
  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes
Distribution Channel:
  • Hospitals
  • Retail Pharmacy
Key Players:
  • Hospira (Pfizer)
  • Hikma
  • APP (Fresenius Kabi)
  • Sagent
  • Sandoz (Novartis)
  • Henry Shein
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. 

ContactUs

IMARCGroup
USA:+1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Location: Atlanta, GA, USA

Comments

Post a Comment

Popular posts from this blog

European Frozen Seafood Market is Projected to witness Strong Growth during the Forecast Period

-
Image
According to the latest report by IMARC Group, titled “ European Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 ”, the  European frozen seafood market  reached a value of US$ 21.4 Billion in 2018, growing at a CAGR of 3.7% during 2011-2018. The European continent is intricately linked with the sea and seafood products form a quintessential part of the regional cuisine. These products serve as a rich source of proteins, micronutrients and essential fatty acids, and are low in fat. They are known to promote heart health, ease the symptoms of arthritis, maintain healthy eyesight, and preserve skin moisture, along with offering innumerable other health benefits. As these products are highly perishable, they require freezing for extending their shelf-life. The freezing process employs advanced techniques like cryofreezing to freeze the products below 200? C. This helps in sealing the flavor and nutrients in the food products for an exte
Read more

Adult Diaper Market is Set for Strong Growth and reaching a value of US$ 20.28 Billion by 2024

-
Image
The latest report by IMARC Group, titled “ Adult Diaper Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 ”, estimates that the  global adult diaper market  reached a value of US$ 13.25 Billion in 2018, exhibiting a CAGR of 8.43% during 2011-2018. Adult diaper refers to a type of underwear which is used by people suffering from problems such as incontinence, dementia, mobility injury and severe diarrhea. Apart from this, it is also worn by astronauts, guards on long duties, divers under their diving suits and other long-hour workers. Adult diapers are composed of comfortable and leakage protective materials which absorb the waste and prevent it from leaking and soiling the outer clothes. The development of convenient and easy-to-wear thin diapers with improved fluid absorption and retention abilities has influenced the sales of adult diapers. Request to get the sample report:  https://www.imarcgroup.com/adult-diaper-market/requestsample Glob
Read more

Indian Shrimp Feed Market is Expected to Experience a strong Growth during the Forecast Period

-
Image
The latest report by IMARC Group, titled “ Indian Shrimp Feed Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 ”, finds that the  Indian shrimp feed market size  exceeded 1 Million Tons in 2018. Shrimp feed is formulated with essential nutrients required for the healthy growth of shrimp. Most of the commercial shrimp feeds are manufactured by pelletizers using a wide variety of plant and animal feedstuffs. Some of the common ingredients include fish and squid meal, lecithin, fish oil, cereal flour and other essential and propriety additives. The use of high-quality feed aids in maximizing profits, improving shrimp production and minimizing the environmental pollution generated by shrimp farming. However, the nutrient profile of shrimp feed depends on numerous factors, such as the stability of the feed, culture density, environmental conditions and feeding method. As a result, feed producers are undertaking research and development activities to enhan
Read more